Targeting p53 in MDS: Highlights From SOHO 2021
Alexis C. Geppner, MLS, CTTS, PA-C
J Adv Pract Oncol 2022;13(suppl 1):15–16 |
© 2022 Harborside™
Alexis C. Geppner, MLS, CTTS, PA-C, of The University of Texas MD Anderson Cancer Center, evaluates data from the session on p53 in myelodysplastic syndrome presented by David A. Sallman, MD, of H. Lee Moffitt Cancer Center and Research Institute, at the 2021 SOHO Annual Meeting.
For access to the full length article, please sign in